Literature DB >> 24413640

Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.

Sara Varanese1, Paolo Di Ruscio, Leila Ben M' Barek, Astrid Thomas, Marco Onofrj.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24413640     DOI： 10.1007/s00415-013-7232-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.

Authors:  Tobias Warnecke; Stephan Oelenberg; Inga Teismann; Christina Hamacher; Hubertus Lohmann; Erich Bernd Ringelstein; Rainer Dziewas
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

2.  Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Authors:  Helen Ling; Luke A Massey; Andrew J Lees; Peter Brown; Brian L Day
Journal:  Brain       Date:  2012-03-06       Impact factor: 13.501

Review 3.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

4.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

5.  Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.

Authors:  J Müller; G K Wenning; M Verny; A McKee; K R Chaudhuri; K Jellinger; W Poewe; I Litvan
Journal:  Arch Neurol       Date:  2001-02

6.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

7.  Study of the rostral midbrain atrophy in progressive supranuclear palsy.

Authors:  Naoko Kato; Kimihito Arai; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2003-06-15       Impact factor: 3.181

8.  Pharmacological therapy in progressive supranuclear palsy.

Authors:  K Kompoliti; C G Goetz; I Litvan; K Jellinger; M Verny
Journal:  Arch Neurol       Date:  1998-08

9.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Authors:  I Litvan; C A Mangone; A McKee; M Verny; A Parsa; K Jellinger; L D'Olhaberriague; K R Chaudhuri; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

10.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Authors:  David R Williams; Rohan de Silva; Dominic C Paviour; Alan Pittman; Hilary C Watt; Linda Kilford; Janice L Holton; Tamas Revesz; Andrew J Lees
Journal:  Brain       Date:  2005-03-23       Impact factor: 13.501
  10 in total
  4 in total

1.  Dysphagia in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Julie A G Stierwalt; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Jennifer L Whitwell; Keith A Josephs
Journal:  Dysphagia       Date:  2019-11-01       Impact factor: 3.438

2.  Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study.

Authors:  Satoshi Tomita; Tomoko Oeda; Atsushi Umemura; Masayuki Kohsaka; Kwiyoung Park; Kenji Yamamoto; Hiroshi Sugiyama; Chiaki Mori; Kimiko Inoue; Harutoshi Fujimura; Hideyuki Sawada
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Planning for an uncertain future in progressive neurological disease: a qualitative study of patient and family decision-making with a focus on eating and drinking.

Authors:  Gemma Clarke; Elizabeth Fistein; Anthony Holland; Jake Tobin; Sam Barclay; Stephen Barclay
Journal:  BMC Neurol       Date:  2018-08-16       Impact factor: 2.474

Review 4.  Management of Dysphagia in Patients with Parkinson's Disease and Related Disorders.

Authors:  George Umemoto; Hirokazu Furuya
Journal:  Intern Med       Date:  2019-04-17       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.